Neonates with severe or moderate vs. mild bronchopulmonary dysplasia had a larger ciliary beat bended angle and a smaller ...

The study authors say flu or RSV may increase the risk of S pneumoniae infection by damaging the bronchi and lung epithelium, ...

Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines ...

Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease of lung parenchymal scarring that is triggered by ...

LTI-03 is formulated as a dry powder inhalation therapy that's designed to help ease fibrosis and symptoms of idiopathic ...

NeoGenomics has commercially launched the c-MET Companion Diagnostic (CDx) for use in non-small cell lung cancer (NSCLC), ...

Two recent studies from The Institute suggest that cannabis vapour may have adverse effects on lung cellsIs vaping cannabis ...

A surge in clinical trials investigating potential idiopathic pulmonary fibrosis therapies offers patients new hope, ...

Rein Therapeutics has initiated the randomised RENEW Phase II trial of its Caveolin-1-related peptide, LTI-03, targeting idiopathic pulmonary fibrosis (IPF), with subject screening and recruitment now ...

A little-known drug may offer hope for a currently incurable and deadly condition, with many patients dying within three years of diagnosis. Idiopathic Pulmonary Fibrosis (IPF) is a progressive and ...